Nadine Godsman
Metabolic alterations in a rat model of takotsubo syndrome.
Godsman, Nadine; Kohlhaas, Michael; Nickel, Alexander; Cheyne, Lesley; Mingarelli, Marco; Schweiger, Lutz; Hepburn, Claire; Munts, Chantal; Welch, Andy; Delibegovic, Mirela; Bilsen, Marc Van; Maack, Christoph; Dawson, Dana K.
Authors
Michael Kohlhaas
Alexander Nickel
Lesley Cheyne
Marco Mingarelli
Lutz Schweiger
Claire Hepburn
Chantal Munts
Andy Welch
Mirela Delibegovic
Marc Van Bilsen
Christoph Maack
Dana K. Dawson
Abstract
Cardiac energetic impairment is a major finding in takotsubo patients. We investigate specific metabolic adaptations to direct future therapies. An isoprenaline-injection female rat model (vs. sham) was studied at Day 3; recovery assessed at Day 7. Substrate uptake, metabolism, inflammation, and remodelling were investigated by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography, metabolomics, quantitative PCR, and western blot (WB). Isolated cardiomyocytes were patch-clamped during stress protocols for redox states of NAD(P)H/FAD or [Ca2+]c, [Ca2+]m, and sarcomere length. Mitochondrial respiration was assessed by seahorse/Clark electrode (glycolytic and β-oxidation substrates). Cardiac 18F-FDG metabolic rate was increased in takotsubo (P = 0.006), as was the expression of GLUT4-RNA/GLUT1/HK2-RNA and HK activity (all P < 0.05), with concomitant accumulation of glucose-and fructose-6-phosphates (P > 0.0001). Both lactate and pyruvate were lower (P < 0.05) despite increases in LDH-RNA and PDH (P < 0.05 both). β-Oxidation enzymes CPT1b-RNA and 3-ketoacyl-CoA thiolase were increased (P < 0.01) but malonyl-CoA (CPT-1 regulator) was upregulated (P = 0.01) with decreased fatty acids and acyl-carnitines levels (P = 0.0001-0.02). Krebs cycle intermediates α-ketoglutarate and succinyl-carnitine were reduced (P < 0.05) as was cellular ATP reporter dihydroorotate (P = 0.003). Mitochondrial Ca2+ uptake during high workload was impaired on Day 3 (P < 0.0001), inducing the oxidation of NAD(P)H and FAD (P = 0.03) but resolved by Day 7. There were no differences in mitochondrial respiratory function, sarcomere shortening, or [Ca2+] transients of isolated cardiomyocytes, implying preserved integrity of both mitochondria and cardiomyocyte. Inflammation and remodelling were upregulated-increased CD68-RNA, collagen RNA/protein, and skeletal actin RNA (all P < 0.05). Dysregulation of glucose and lipid metabolic pathways with decreases in final glycolytic and β-oxidation metabolites and reduced availability of Krebs intermediates characterizes takotsubo myocardium. The energetic deficit accompanies defective Ca2+ handling, inflammation, and upregulation of remodelling pathways, with the preservation of sarcomeric and mitochondrial integrity.
Citation
GODSMAN, N., KOHLHASS, M., NICKEL, A., CHEYNE, L., MINGARELLI, M., SCHWEIGHER, L., HEPBURN, C., MUNTS, C., WELCH, A., DELIBEGOVIC, M., BILSEN, M. VAN., MAACK, C. and DAWSON, D.K. 2022. Metabolic alterations in a rat model of takotsubo syndrome. Cardiovascular research [online], 118(8), pages 1932-1946. Available from: https://doi.org/10.1093/cvr/cvab081
Journal Article Type | Article |
---|---|
Acceptance Date | Mar 9, 2021 |
Online Publication Date | Mar 12, 2021 |
Publication Date | May 31, 2022 |
Deposit Date | Oct 15, 2024 |
Publicly Available Date | Oct 15, 2024 |
Journal | Cardiovascular research |
Print ISSN | 0008-6363 |
Electronic ISSN | 1755-3245 |
Publisher | Oxford University Press |
Peer Reviewed | Peer Reviewed |
Volume | 118 |
Issue | 8 |
Pages | 1932-1946 |
DOI | https://doi.org/10.1093/cvr/cvab081 |
Keywords | Takotsubo; Metabolism; Energetics; Inflammation; Remodelling; Heart failure |
Public URL | https://rgu-repository.worktribe.com/output/2516332 |
Additional Information | This article has been published with separate supporting information. This supporting information has been incorporated into a single file on this repository and can be found at the end of the file associated with this output. |
Files
GODSMAN 2022 Metabolic alterations (VOR)
(2.2 Mb)
PDF
Licence
https://creativecommons.org/licenses/by/4.0/
Copyright Statement
© The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
You might also like
Downloadable Citations
About OpenAIR@RGU
Administrator e-mail: publications@rgu.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search